Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Yvonne Bury

Newcastle AuthorsTitleYearFull text
Dr Beate Haugk
Dr Yvonne Bury
Pancreatic pathology: where are we in 2019?2019
Dr Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al.
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis2017
Dr Beate Haugk
Dr Yvonne Bury
Dr Louise Coats
Dr John O'Sullivan
Dr Mark Hudson
et al.
Defining the role of liver biopsy in the assessment of liver fibrosis in patients with Fontan circulation2017
Professor Colin Rees
Dr Yvonne Bury
Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?2016
Professor Quentin Anstee
Professor Chris Day
Professor Alastair Burt
Dr John Brain
Dr Yvonne Bury
et al.
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference2016
Dr Dina Tiniakos Tiniakos
Dr Yvonne Bury
p62 (SQSTM1) expression in human liver disease: Preliminary results2015
Dr Dina Tiniakos Tiniakos
Dr John Brain
Dr Yvonne Bury
Role of Histopathology in Autoimmune Hepatitis2015
Dr Yvonne Bury
Naomi Brown
Dr Dina Tiniakos Tiniakos
p53 expression in human hepatocellular carcinoma (HCC): correlation with dysadherin expression and patient prognosis2014
David Bradburn
Dr Yvonne Bury
Professor Colin Rees
Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers2014
Dr Yvonne Bury
The enhanced role of biomedical scientists in the histological dissection of axillary lymph node clearance specimens2014
12